Bold Capital Partners
Venture Capital
Active
Santa Monica, United States
95
17M
54
10.56
10
0.41
3
- Stages of investment
- Areas of investment
Summary
Bold Capital Partners is the famous VC, which was founded in 2015. The company was established in North America in United States. The leading representative office of defined VC is situated in the Santa Monica.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Bold Capital Partners, startups are often financed by Khosla Ventures, Y Combinator, Western Technology Investment. The meaningful sponsors for the fund in investment in the same round are Khosla Ventures, Horizons Ventures, Greycroft. In the next rounds fund is usually obtained by DP World Group, Y Combinator, Tencent Holdings.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Computer, Software. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Insilico Medicine, AliveCor, Terramera.
The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The average startup value when the investment from Bold Capital Partners is 10-50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides them, we counted 4 critical employees of this fund in our database.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 95
- Lead investments
- 10
- Exits
- 3
- Rounds per year
- 10.56
- Follow on index
- 0.41
- Investments by industry
- Health Care (34)
- Biotechnology (23)
- Software (17)
- Artificial Intelligence (16)
- Medical (13) Show 98 more
- Investments by region
-
- United States (83)
- China (6)
- Canada (2)
- Finland (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 56M
- Group Appearance index
- 0.96
- Avg. company exit year
- 3
- Avg. multiplicator
- 4.18
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Switch Therapeutics | 14 Mar 2023 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 52M | United States, California, San Francisco |
| Syntis Bio | 17 Jan 2023 | Seed | 15M | United States, Massachusetts, Milton |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.